Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | PF562271 | 0.100 | 1.000 | uM | 72 | hr | 3 | 1142 | 316 | 0.1490 | 0.1528 | 0.2767 | 0.2918 |
COLO 858 | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 1 | 912 | 724 | 0.0339 | 0.0290 | 0.7939 | 0.7843 |
COLO 858 | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 2 | 723 | 550 | 0.0312 | 0.0290 | 0.7607 | 0.7843 |
COLO 858 | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 3 | 600 | 479 | 0.0218 | 0.0290 | 0.7983 | 0.7843 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 1 | 1748 | 230 | 0.2738 | 0.2879 | 0.1316 | 0.1549 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 2 | 1817 | 313 | 0.2712 | 0.2879 | 0.1723 | 0.1549 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 3 | 2106 | 339 | 0.3187 | 0.2879 | 0.1610 | 0.1549 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 1 | 1301 | 460 | 0.1517 | 0.1439 | 0.3536 | 0.3763 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 2 | 1253 | 524 | 0.1315 | 0.1439 | 0.4182 | 0.3763 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 3 | 1280 | 457 | 0.1484 | 0.1439 | 0.3570 | 0.3763 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 1 | 1035 | 564 | 0.0849 | 0.0793 | 0.5449 | 0.5384 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 2 | 956 | 466 | 0.0884 | 0.0793 | 0.4874 | 0.5384 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 3 | 858 | 500 | 0.0646 | 0.0793 | 0.5828 | 0.5384 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 1 | 526 | 473 | 0.0096 | 0.0109 | 0.8992 | 0.8930 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 2 | 670 | 585 | 0.0153 | 0.0109 | 0.8731 | 0.8930 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 3 | 471 | 427 | 0.0079 | 0.0109 | 0.9066 | 0.8930 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 1 | 1250 | 489 | 0.1372 | 0.1377 | 0.3912 | 0.4424 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 2 | 1366 | 641 | 0.1307 | 0.1377 | 0.4693 | 0.4424 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 3 | 1510 | 705 | 0.1452 | 0.1377 | 0.4669 | 0.4424 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 1 | 1154 | 797 | 0.0644 | 0.0514 | 0.6906 | 0.7028 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 2 | 921 | 673 | 0.0447 | 0.0514 | 0.7307 | 0.7028 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 3 | 799 | 549 | 0.0451 | 0.0514 | 0.6871 | 0.7028 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 1 | 942 | 775 | 0.0301 | 0.0248 | 0.8227 | 0.8407 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 2 | 833 | 687 | 0.0263 | 0.0248 | 0.8247 | 0.8407 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 3 | 790 | 691 | 0.0179 | 0.0248 | 0.8747 | 0.8407 |